# Antioxidant and Immunomodulator Properties of Viusid in Patients With Chronic Hepatitis C

> **NCT00778843** · PHASE3 · COMPLETED · sponsor: **Catalysis SL** · enrollment: 60 (actual)

## Conditions studied

- Chronic Hepatitis C

## Interventions

- **DIETARY_SUPPLEMENT:** Viusid
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT00778843
- **Lead sponsor:** Catalysis SL
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-10
- **Primary completion:** 2009-05
- **Final completion:** 2009-05
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2012-05-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00778843

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00778843, "Antioxidant and Immunomodulator Properties of Viusid in Patients With Chronic Hepatitis C". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT00778843. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*